University of Calgary: Depressive Disorder, Major trials

The registry lists 10 Depressive Disorder, Major studies with University of Calgary as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 2Phase 3 1Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive DisorderRecruitingNCT04805879Phase 2/3
• Pharmacogenetics of Antidepressant-Induced DisinhibitionRecruitingNCT03953014
• Transcranial Magnetic Stimulation for Adolescent DepressionCompletedNCT01731678Not applicableResults posted
• D-Cycloserine+iTBS PK StudyCompletedNCT05731323Phase 1
• Adjunctive D-Cycloserine in Major Depressive DisorderCompletedNCT03937596Phase 2
• Biomarkers of Theta Burst Stimulation in Major Depressive DisorderStatus unknownNCT03626181Not applicable
• Cycloserine rTMS Plasticity Augmentation in DepressionCompletedNCT03511599Phase 1
• Adolescent Mental Health: Canadian Psychiatric Risk and Outcome StudyCompletedNCT02739932
• Prediction of Antidepressant Treatment Response Using Machine Learning Classification AnalysisStatus unknownNCT02330679Phase 4
• Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major DepressionCompletedNCT02132286Phase 4